
Proposing a New Classification for Managing Prostaglandin-Induced Enophthalmos in Glaucoma Patients
Introduction Glaucoma, a leading cause of irreversible blindness, is commonly managed with prostaglandin analogs (PGAs), which are effective in reducing intraocular pressure (IOP). Despite their benefits, PGAs such as latanoprost, bimatoprost, and …